Here, the authors report a phase 2 clinical trial investigating immune activation and efficacy of neoadjuvant pembrolizumab administered after one cycle of neo-adjuvant chemotherapy in patients ...

The first patient has been dosed in a phase 1/2 clinical trial evaluating KSQ-004EX in solid tumors including melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC ...

YANTAI, China, April 8, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym ...

The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have ...

Rather than viewing this as a threat, the clinical trial community has an opportunity to connect with highly engaged—but not always well-informed—healthcare consumers who are hungrier for information ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

(3) Only 7% of Indian patients with diabetes have controlled HbA1c, blood pressure, and cholesterol, indicating poor CV risk factor control. (5) Why Global Aspirin Primary Prevention Trials May Not ...

A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating refractory CD30-positive lymphomas.

IoT can be used in clinical trials to increase patient accessibility, often by decentralising the trials. Credit: metamorworks via Shutterstock. Clinical trials often place a significant burden on ...

The Swiss drugmaker, which holds European rights to Elevidys, suspended three trials while researchers investigate the death of a young man who died following treatment. News of the patient’s death in ...

A Worcester-based non-emergency medical transportation company and its owner have been indicted for alleged patient abuse and ... writer at Worcester Business Journal, who primarily covers the ...

Matching yielded 160 patients in each arm with minimal differences in prognostic variables between the matched groups, who will be compared to evaluate the efficacy and safety of darolutamide plus ADT ...